Aligos Therapeutics
ALGS
ALGS
35 hedge funds and large institutions have $27.1M invested in Aligos Therapeutics in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% less capital invested
Capital invested by funds: $64.5M → $27.1M (-$37.4M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $14K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$14K
Top Buyers
| 1 | +$3.4M | |
| 2 | +$2.6M | |
| 3 | +$1.99M | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.88M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$1.65M |
Top Sellers
| 1 | -$2.56M | |
| 2 | -$1.6M | |
| 3 | -$1.38M | |
| 4 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
-$1.22M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$1.09M |
